WY-47766
Code | Size | Price |
---|
TAR-T29164-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T29164-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T29164-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
WY-47766, a proton pump inhibitor, is used potentially for the treatment of postmenopausal osteoporosis.
CAS:
134217-27-9
Formula:
C14H13N3O2S
Molecular Weight:
287.34
Purity:
0.98
SMILES:
COc1cccc(CS(=O)c2nc3ccncc3[nH]2)c1
References
1. Major PP, Lipton A, Berenson J, Hortobagyi G. Oral bisphosphonates: A review of clinical use in patients with bone metastases. Cancer. 2000 Jan 1;88(1):6-14. Review. PubMed PMID: 10618600.
2. Morris SA, Shen H, Bex FJ, Bilezikian JP. Influence of antiresorptive agent OST-766 on signal transduction pathways involved in parathyroid hormone action. Calcif Tissue Int. 1999 Feb;64(2):148-53. PubMed PMID: 9914323.
3. Hall TJ, Schaueblin M. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase. Bone Miner. 1994 Nov;27(2):159-66. PubMed PMID: 7711523.